nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—MPO—Dapsone—malaria	0.276	0.414	CbGbCtD
Nabumetone—PTGS2—Dapsone—malaria	0.0954	0.143	CbGbCtD
Nabumetone—PTGS1—Dapsone—malaria	0.0806	0.121	CbGbCtD
Nabumetone—CYP1A2—Proguanil—malaria	0.0737	0.11	CbGbCtD
Nabumetone—CYP1A2—Pentoxifylline—malaria	0.0529	0.0792	CbGbCtD
Nabumetone—CYP1A2—Quinine—malaria	0.0475	0.0711	CbGbCtD
Nabumetone—CYP1A2—Quinidine—malaria	0.0417	0.0625	CbGbCtD
Nabumetone—MPO—saliva—malaria	0.0127	0.183	CbGeAlD
Nabumetone—MPO—endothelium—malaria	0.00623	0.0896	CbGeAlD
Nabumetone—MPO—blood plasma—malaria	0.00554	0.0795	CbGeAlD
Nabumetone—MPO—Vitamin B12 Metabolism—HBB—malaria	0.00312	0.0523	CbGpPWpGaD
Nabumetone—MPO—hematopoietic system—malaria	0.00306	0.044	CbGeAlD
Nabumetone—CYP1A2—blood plasma—malaria	0.00303	0.0435	CbGeAlD
Nabumetone—PTGS1—endothelium—malaria	0.00296	0.0425	CbGeAlD
Nabumetone—PTGS2—endothelium—malaria	0.00283	0.0406	CbGeAlD
Nabumetone—PTGS1—blood plasma—malaria	0.00263	0.0377	CbGeAlD
Nabumetone—MPO—Folate Metabolism—HBB—malaria	0.00254	0.0426	CbGpPWpGaD
Nabumetone—PTGS2—blood plasma—malaria	0.00251	0.0361	CbGeAlD
Nabumetone—MPO—kidney—malaria	0.00251	0.0361	CbGeAlD
Nabumetone—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.00218	0.0365	CbGpPWpGaD
Nabumetone—MPO—digestive system—malaria	0.00213	0.0306	CbGeAlD
Nabumetone—MPO—IL23-mediated signaling events—IL12B—malaria	0.00207	0.0346	CbGpPWpGaD
Nabumetone—MPO—blood—malaria	0.00203	0.0291	CbGeAlD
Nabumetone—MPO—Selenium Micronutrient Network—HBB—malaria	0.00202	0.0338	CbGpPWpGaD
Nabumetone—MPO—bone marrow—malaria	0.00196	0.0282	CbGeAlD
Nabumetone—MPO—Vitamin B12 Metabolism—SCARB1—malaria	0.00174	0.0291	CbGpPWpGaD
Nabumetone—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—malaria	0.00173	0.029	CbGpPWpGaD
Nabumetone—CYP1A2—hematopoietic system—malaria	0.00168	0.0241	CbGeAlD
Nabumetone—MPO—liver—malaria	0.00159	0.0228	CbGeAlD
Nabumetone—MPO—IL23-mediated signaling events—IL18—malaria	0.00152	0.0254	CbGpPWpGaD
Nabumetone—PTGS1—hematopoietic system—malaria	0.00145	0.0209	CbGeAlD
Nabumetone—MPO—Folate Metabolism—DHFR—malaria	0.00143	0.0239	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—SCARB1—malaria	0.00141	0.0237	CbGpPWpGaD
Nabumetone—PTGS2—hematopoietic system—malaria	0.00139	0.0199	CbGeAlD
Nabumetone—MPO—brain—malaria	0.00126	0.0181	CbGeAlD
Nabumetone—PTGS1—kidney—malaria	0.00119	0.0171	CbGeAlD
Nabumetone—CYP1A2—digestive system—malaria	0.00117	0.0167	CbGeAlD
Nabumetone—MPO—IL23-mediated signaling events—NOS2—malaria	0.00116	0.0194	CbGpPWpGaD
Nabumetone—PTGS2—kidney—malaria	0.00114	0.0163	CbGeAlD
Nabumetone—MPO—Selenium Micronutrient Network—SCARB1—malaria	0.00112	0.0188	CbGpPWpGaD
Nabumetone—CYP1A2—blood—malaria	0.00111	0.016	CbGeAlD
Nabumetone—PTGS1—digestive system—malaria	0.00101	0.0145	CbGeAlD
Nabumetone—MPO—Vitamin B12 Metabolism—CRP—malaria	0.000983	0.0165	CbGpPWpGaD
Nabumetone—PTGS2—digestive system—malaria	0.000966	0.0139	CbGeAlD
Nabumetone—PTGS1—blood—malaria	0.000962	0.0138	CbGeAlD
Nabumetone—MPO—Folate Metabolism—IL4—malaria	0.000925	0.0155	CbGpPWpGaD
Nabumetone—PTGS2—blood—malaria	0.00092	0.0132	CbGeAlD
Nabumetone—MPO—Vitamin B12 Metabolism—ICAM1—malaria	0.000903	0.0151	CbGpPWpGaD
Nabumetone—PTGS2—bone marrow—malaria	0.00089	0.0128	CbGeAlD
Nabumetone—MPO—IL23-mediated signaling events—IFNG—malaria	0.000888	0.0149	CbGpPWpGaD
Nabumetone—PTGS1—Overview of nanoparticle effects—CRP—malaria	0.000886	0.0148	CbGpPWpGaD
Nabumetone—CYP1A2—liver—malaria	0.000868	0.0125	CbGeAlD
Nabumetone—MPO—IL23-mediated signaling events—CD4—malaria	0.000858	0.0144	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—HBB—malaria	0.000826	0.0138	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—CRP—malaria	0.000799	0.0134	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IL1B—malaria	0.000792	0.0133	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IL2—malaria	0.000789	0.0132	CbGpPWpGaD
Nabumetone—PTGS1—Arachidonic acid metabolism—HPGDS—malaria	0.000787	0.0132	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—ICAM1—malaria	0.000735	0.0123	CbGpPWpGaD
Nabumetone—Toxic epidermal necrolysis—Quinidine barbiturate—malaria	0.000734	0.00362	CcSEcCtD
Nabumetone—Photosensitivity reaction—Clindamycin—malaria	0.000727	0.00359	CcSEcCtD
Nabumetone—Body temperature increased—Proguanil—malaria	0.000724	0.00357	CcSEcCtD
Nabumetone—Abdominal pain—Proguanil—malaria	0.000724	0.00357	CcSEcCtD
Nabumetone—PTGS2—liver—malaria	0.000719	0.0103	CbGeAlD
Nabumetone—Photosensitivity reaction—Quinine—malaria	0.000713	0.00352	CcSEcCtD
Nabumetone—Photosensitivity reaction—Quinidine—malaria	0.000713	0.00352	CcSEcCtD
Nabumetone—Asthma—Quinidine barbiturate—malaria	0.000705	0.00348	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Clindamycin—malaria	0.000704	0.00347	CcSEcCtD
Nabumetone—PTGS2—Overview of nanoparticle effects—CRP—malaria	0.000703	0.0118	CbGpPWpGaD
Nabumetone—Jaundice—Clindamycin—malaria	0.000692	0.00341	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Quinine—malaria	0.00069	0.00341	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Quinidine—malaria	0.00069	0.00341	CcSEcCtD
Nabumetone—MPO—Vitamin B12 Metabolism—IFNG—malaria	0.000687	0.0115	CbGpPWpGaD
Nabumetone—Angina pectoris—Quinidine barbiturate—malaria	0.000687	0.00339	CcSEcCtD
Nabumetone—Angina pectoris—Pentoxifylline—malaria	0.000685	0.00338	CcSEcCtD
Nabumetone—Renal failure—Quinidine—malaria	0.000684	0.00338	CcSEcCtD
Nabumetone—Renal failure—Quinine—malaria	0.000684	0.00338	CcSEcCtD
Nabumetone—Jaundice—Quinidine—malaria	0.000679	0.00335	CcSEcCtD
Nabumetone—Jaundice—Quinine—malaria	0.000679	0.00335	CcSEcCtD
Nabumetone—PTGS2—S1P1 pathway—KDR—malaria	0.000674	0.0113	CbGpPWpGaD
Nabumetone—Vertigo—Sulfadiazine—malaria	0.000669	0.0033	CcSEcCtD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000667	0.0112	CbGpPWpGaD
Nabumetone—Leukopenia—Sulfadiazine—malaria	0.000667	0.00329	CcSEcCtD
Nabumetone—Agranulocytosis—Clindamycin—malaria	0.000662	0.00327	CcSEcCtD
Nabumetone—PTGS2—Selenium Micronutrient Network—HBB—malaria	0.000656	0.011	CbGpPWpGaD
Nabumetone—Agranulocytosis—Quinidine—malaria	0.00065	0.00321	CcSEcCtD
Nabumetone—Agranulocytosis—Quinine—malaria	0.00065	0.00321	CcSEcCtD
Nabumetone—Photosensitivity reaction—Quinidine barbiturate—malaria	0.000643	0.00317	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—CRP—malaria	0.000635	0.0106	CbGpPWpGaD
Nabumetone—Haemoglobin—Quinidine—malaria	0.000628	0.0031	CcSEcCtD
Nabumetone—Haemoglobin—Quinine—malaria	0.000628	0.0031	CcSEcCtD
Nabumetone—Diarrhoea—Proguanil—malaria	0.000627	0.00309	CcSEcCtD
Nabumetone—Haemorrhage—Quinidine—malaria	0.000625	0.00308	CcSEcCtD
Nabumetone—Haemorrhage—Quinine—malaria	0.000625	0.00308	CcSEcCtD
Nabumetone—PTGS2—Arachidonic acid metabolism—HPGDS—malaria	0.000624	0.0105	CbGpPWpGaD
Nabumetone—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.000623	0.00307	CcSEcCtD
Nabumetone—Renal failure—Quinidine barbiturate—malaria	0.000618	0.00305	CcSEcCtD
Nabumetone—Tinnitus—Dapsone—malaria	0.000614	0.00303	CcSEcCtD
Nabumetone—MPO—Vitamin B12 Metabolism—IL1B—malaria	0.000613	0.0103	CbGpPWpGaD
Nabumetone—Jaundice—Quinidine barbiturate—malaria	0.000613	0.00302	CcSEcCtD
Nabumetone—Jaundice—Pentoxifylline—malaria	0.000611	0.00302	CcSEcCtD
Nabumetone—Anaphylactic shock—Sulfadiazine—malaria	0.000608	0.003	CcSEcCtD
Nabumetone—Erythema multiforme—Clindamycin—malaria	0.000602	0.00297	CcSEcCtD
Nabumetone—Visual impairment—Quinine—malaria	0.000602	0.00297	CcSEcCtD
Nabumetone—Visual impairment—Quinidine—malaria	0.000602	0.00297	CcSEcCtD
Nabumetone—PTGS1—brain—malaria	0.000597	0.00858	CbGeAlD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—malaria	0.000596	0.00999	CbGpPWpGaD
Nabumetone—Thrombocytopenia—Sulfadiazine—malaria	0.000595	0.00294	CcSEcCtD
Nabumetone—Erythema multiforme—Quinidine—malaria	0.000591	0.00292	CcSEcCtD
Nabumetone—Erythema multiforme—Quinine—malaria	0.000591	0.00292	CcSEcCtD
Nabumetone—Agranulocytosis—Quinidine barbiturate—malaria	0.000586	0.00289	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—ICAM1—malaria	0.000584	0.00978	CbGpPWpGaD
Nabumetone—Tinnitus—Quinidine—malaria	0.000583	0.00288	CcSEcCtD
Nabumetone—Tinnitus—Quinine—malaria	0.000583	0.00288	CcSEcCtD
Nabumetone—Vomiting—Proguanil—malaria	0.000582	0.00287	CcSEcCtD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—malaria	0.00058	0.00972	CbGpPWpGaD
Nabumetone—Anorexia—Sulfadiazine—malaria	0.000579	0.00286	CcSEcCtD
Nabumetone—Rash—Proguanil—malaria	0.000577	0.00285	CcSEcCtD
Nabumetone—Dermatitis—Proguanil—malaria	0.000577	0.00285	CcSEcCtD
Nabumetone—MPO—IL23-mediated signaling events—TNF—malaria	0.000575	0.00963	CbGpPWpGaD
Nabumetone—Headache—Proguanil—malaria	0.000574	0.00283	CcSEcCtD
Nabumetone—PTGS2—brain—malaria	0.000571	0.0082	CbGeAlD
Nabumetone—Haemoglobin—Quinidine barbiturate—malaria	0.000567	0.0028	CcSEcCtD
Nabumetone—Haemoglobin—Pentoxifylline—malaria	0.000566	0.00279	CcSEcCtD
Nabumetone—Haemorrhage—Quinidine barbiturate—malaria	0.000564	0.00278	CcSEcCtD
Nabumetone—Haemorrhage—Pentoxifylline—malaria	0.000563	0.00278	CcSEcCtD
Nabumetone—Chills—Quinidine—malaria	0.000561	0.00277	CcSEcCtD
Nabumetone—Chills—Quinine—malaria	0.000561	0.00277	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—IFNG—malaria	0.000559	0.00937	CbGpPWpGaD
Nabumetone—Insomnia—Sulfadiazine—malaria	0.00055	0.00271	CcSEcCtD
Nabumetone—Flatulence—Clindamycin—malaria	0.000547	0.0027	CcSEcCtD
Nabumetone—Nausea—Proguanil—malaria	0.000544	0.00268	CcSEcCtD
Nabumetone—Visual impairment—Quinidine barbiturate—malaria	0.000544	0.00268	CcSEcCtD
Nabumetone—Erythema multiforme—Quinidine barbiturate—malaria	0.000533	0.00263	CcSEcCtD
Nabumetone—Decreased appetite—Sulfadiazine—malaria	0.000528	0.00261	CcSEcCtD
Nabumetone—Tinnitus—Quinidine barbiturate—malaria	0.000526	0.0026	CcSEcCtD
Nabumetone—Vertigo—Dapsone—malaria	0.000515	0.00254	CcSEcCtD
Nabumetone—Anaemia—Clindamycin—malaria	0.000513	0.00253	CcSEcCtD
Nabumetone—Tremor—Quinidine—malaria	0.00051	0.00252	CcSEcCtD
Nabumetone—Tremor—Quinine—malaria	0.00051	0.00252	CcSEcCtD
Nabumetone—Chills—Quinidine barbiturate—malaria	0.000506	0.0025	CcSEcCtD
Nabumetone—Arrhythmia—Pentoxifylline—malaria	0.000503	0.00248	CcSEcCtD
Nabumetone—Cough—Dapsone—malaria	0.0005	0.00247	CcSEcCtD
Nabumetone—Agitation—Quinine—malaria	0.0005	0.00247	CcSEcCtD
Nabumetone—Agitation—Quinidine—malaria	0.0005	0.00247	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—IL1B—malaria	0.000499	0.00836	CbGpPWpGaD
Nabumetone—Vertigo—Clindamycin—malaria	0.000498	0.00246	CcSEcCtD
Nabumetone—Angioedema—Quinine—malaria	0.000497	0.00245	CcSEcCtD
Nabumetone—Angioedema—Quinidine—malaria	0.000497	0.00245	CcSEcCtD
Nabumetone—Gastrointestinal pain—Sulfadiazine—malaria	0.000497	0.00245	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—IL2—malaria	0.000497	0.00832	CbGpPWpGaD
Nabumetone—Leukopenia—Clindamycin—malaria	0.000497	0.00245	CcSEcCtD
Nabumetone—Vertigo—Quinidine—malaria	0.000489	0.00241	CcSEcCtD
Nabumetone—Vertigo—Quinine—malaria	0.000489	0.00241	CcSEcCtD
Nabumetone—Syncope—Quinidine—malaria	0.000488	0.00241	CcSEcCtD
Nabumetone—Syncope—Quinine—malaria	0.000488	0.00241	CcSEcCtD
Nabumetone—Leukopenia—Quinine—malaria	0.000487	0.0024	CcSEcCtD
Nabumetone—Leukopenia—Quinidine—malaria	0.000487	0.0024	CcSEcCtD
Nabumetone—Flatulence—Pentoxifylline—malaria	0.000483	0.00238	CcSEcCtD
Nabumetone—Urticaria—Sulfadiazine—malaria	0.000483	0.00238	CcSEcCtD
Nabumetone—Tension—Quinidine barbiturate—malaria	0.000482	0.00238	CcSEcCtD
Nabumetone—Tension—Pentoxifylline—malaria	0.000481	0.00237	CcSEcCtD
Nabumetone—Palpitations—Quinidine—malaria	0.000481	0.00237	CcSEcCtD
Nabumetone—Palpitations—Quinine—malaria	0.000481	0.00237	CcSEcCtD
Nabumetone—Body temperature increased—Sulfadiazine—malaria	0.000481	0.00237	CcSEcCtD
Nabumetone—Abdominal pain—Sulfadiazine—malaria	0.000481	0.00237	CcSEcCtD
Nabumetone—Hypertension—Clindamycin—malaria	0.000479	0.00236	CcSEcCtD
Nabumetone—Loss of consciousness—Quinidine—malaria	0.000478	0.00236	CcSEcCtD
Nabumetone—Loss of consciousness—Quinine—malaria	0.000478	0.00236	CcSEcCtD
Nabumetone—Nervousness—Quinidine barbiturate—malaria	0.000477	0.00235	CcSEcCtD
Nabumetone—Nervousness—Pentoxifylline—malaria	0.000476	0.00235	CcSEcCtD
Nabumetone—Discomfort—Clindamycin—malaria	0.000467	0.0023	CcSEcCtD
Nabumetone—MPO—IL23-mediated signaling events—IL6—malaria	0.000464	0.00777	CbGpPWpGaD
Nabumetone—Tremor—Quinidine barbiturate—malaria	0.00046	0.00227	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—SCARB1—malaria	0.000459	0.0077	CbGpPWpGaD
Nabumetone—Tremor—Pentoxifylline—malaria	0.000459	0.00227	CcSEcCtD
Nabumetone—Ill-defined disorder—Pentoxifylline—malaria	0.000455	0.00224	CcSEcCtD
Nabumetone—Anaemia—Pentoxifylline—malaria	0.000453	0.00224	CcSEcCtD
Nabumetone—Anaphylactic shock—Clindamycin—malaria	0.000453	0.00223	CcSEcCtD
Nabumetone—Agitation—Quinidine barbiturate—malaria	0.000451	0.00223	CcSEcCtD
Nabumetone—Agitation—Pentoxifylline—malaria	0.00045	0.00222	CcSEcCtD
Nabumetone—Angioedema—Quinidine barbiturate—malaria	0.000449	0.00221	CcSEcCtD
Nabumetone—Angioedema—Pentoxifylline—malaria	0.000448	0.00221	CcSEcCtD
Nabumetone—Hypersensitivity—Sulfadiazine—malaria	0.000448	0.00221	CcSEcCtD
Nabumetone—Confusional state—Quinine—malaria	0.000448	0.00221	CcSEcCtD
Nabumetone—Confusional state—Quinidine—malaria	0.000448	0.00221	CcSEcCtD
Nabumetone—MPO—C-MYB transcription factor network—CD4—malaria	0.000445	0.00746	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—TNF—malaria	0.000445	0.00745	CbGpPWpGaD
Nabumetone—MPO—Selenium Micronutrient Network—IFNG—malaria	0.000444	0.00744	CbGpPWpGaD
Nabumetone—Oedema—Quinidine—malaria	0.000444	0.00219	CcSEcCtD
Nabumetone—Oedema—Quinine—malaria	0.000444	0.00219	CcSEcCtD
Nabumetone—Thrombocytopenia—Clindamycin—malaria	0.000443	0.00219	CcSEcCtD
Nabumetone—Malaise—Pentoxifylline—malaria	0.000442	0.00218	CcSEcCtD
Nabumetone—Vertigo—Quinidine barbiturate—malaria	0.000441	0.00218	CcSEcCtD
Nabumetone—Syncope—Quinidine barbiturate—malaria	0.00044	0.00217	CcSEcCtD
Nabumetone—Leukopenia—Quinidine barbiturate—malaria	0.00044	0.00217	CcSEcCtD
Nabumetone—Leukopenia—Pentoxifylline—malaria	0.000439	0.00217	CcSEcCtD
Nabumetone—Shock—Quinine—malaria	0.000437	0.00216	CcSEcCtD
Nabumetone—Shock—Quinidine—malaria	0.000437	0.00216	CcSEcCtD
Nabumetone—Thrombocytopenia—Quinidine—malaria	0.000435	0.00215	CcSEcCtD
Nabumetone—Thrombocytopenia—Quinine—malaria	0.000435	0.00215	CcSEcCtD
Nabumetone—Palpitations—Quinidine barbiturate—malaria	0.000434	0.00214	CcSEcCtD
Nabumetone—Palpitations—Pentoxifylline—malaria	0.000433	0.00214	CcSEcCtD
Nabumetone—Loss of consciousness—Quinidine barbiturate—malaria	0.000432	0.00213	CcSEcCtD
Nabumetone—Pruritus—Sulfadiazine—malaria	0.00043	0.00212	CcSEcCtD
Nabumetone—Hyperhidrosis—Quinidine—malaria	0.000429	0.00212	CcSEcCtD
Nabumetone—Hyperhidrosis—Quinine—malaria	0.000429	0.00212	CcSEcCtD
Nabumetone—Anorexia—Quinidine—malaria	0.000423	0.00209	CcSEcCtD
Nabumetone—Anorexia—Quinine—malaria	0.000423	0.00209	CcSEcCtD
Nabumetone—Insomnia—Dapsone—malaria	0.000423	0.00209	CcSEcCtD
Nabumetone—Hypertension—Pentoxifylline—malaria	0.000423	0.00209	CcSEcCtD
Nabumetone—Anxiety—Quinidine barbiturate—malaria	0.000417	0.00206	CcSEcCtD
Nabumetone—Diarrhoea—Sulfadiazine—malaria	0.000416	0.00205	CcSEcCtD
Nabumetone—Anxiety—Pentoxifylline—malaria	0.000416	0.00205	CcSEcCtD
Nabumetone—Discomfort—Pentoxifylline—malaria	0.000412	0.00203	CcSEcCtD
Nabumetone—Dry mouth—Pentoxifylline—malaria	0.000408	0.00201	CcSEcCtD
Nabumetone—Confusional state—Quinidine barbiturate—malaria	0.000404	0.00199	CcSEcCtD
Nabumetone—Dyspnoea—Clindamycin—malaria	0.000404	0.00199	CcSEcCtD
Nabumetone—Confusional state—Pentoxifylline—malaria	0.000403	0.00199	CcSEcCtD
Nabumetone—PTGS1—Overview of nanoparticle effects—TNF—malaria	0.000401	0.00672	CbGpPWpGaD
Nabumetone—Oedema—Quinidine barbiturate—malaria	0.000401	0.00198	CcSEcCtD
Nabumetone—Anaphylactic shock—Pentoxifylline—malaria	0.0004	0.00197	CcSEcCtD
Nabumetone—Oedema—Pentoxifylline—malaria	0.0004	0.00197	CcSEcCtD
Nabumetone—Dyspepsia—Clindamycin—malaria	0.000398	0.00197	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—IL1B—malaria	0.000396	0.00664	CbGpPWpGaD
Nabumetone—Dyspnoea—Quinidine—malaria	0.000396	0.00195	CcSEcCtD
Nabumetone—Dyspnoea—Quinine—malaria	0.000396	0.00195	CcSEcCtD
Nabumetone—Shock—Quinidine barbiturate—malaria	0.000394	0.00195	CcSEcCtD
Nabumetone—Shock—Pentoxifylline—malaria	0.000394	0.00194	CcSEcCtD
Nabumetone—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—malaria	0.000393	0.00659	CbGpPWpGaD
Nabumetone—Thrombocytopenia—Quinidine barbiturate—malaria	0.000392	0.00194	CcSEcCtD
Nabumetone—Thrombocytopenia—Pentoxifylline—malaria	0.000392	0.00193	CcSEcCtD
Nabumetone—Fatigue—Clindamycin—malaria	0.00039	0.00193	CcSEcCtD
Nabumetone—Hyperhidrosis—Quinidine barbiturate—malaria	0.000387	0.00191	CcSEcCtD
Nabumetone—Constipation—Clindamycin—malaria	0.000387	0.00191	CcSEcCtD
Nabumetone—Hyperhidrosis—Pentoxifylline—malaria	0.000387	0.00191	CcSEcCtD
Nabumetone—Vomiting—Sulfadiazine—malaria	0.000387	0.00191	CcSEcCtD
Nabumetone—Decreased appetite—Quinine—malaria	0.000386	0.0019	CcSEcCtD
Nabumetone—Decreased appetite—Quinidine—malaria	0.000386	0.0019	CcSEcCtD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—malaria	0.000386	0.00646	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—CD36—malaria	0.000385	0.00644	CbGpPWpGaD
Nabumetone—Rash—Sulfadiazine—malaria	0.000383	0.00189	CcSEcCtD
Nabumetone—Dermatitis—Sulfadiazine—malaria	0.000383	0.00189	CcSEcCtD
Nabumetone—Gastrointestinal pain—Dapsone—malaria	0.000383	0.00189	CcSEcCtD
Nabumetone—Anorexia—Quinidine barbiturate—malaria	0.000382	0.00189	CcSEcCtD
Nabumetone—Anorexia—Pentoxifylline—malaria	0.000381	0.00188	CcSEcCtD
Nabumetone—Headache—Sulfadiazine—malaria	0.000381	0.00188	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000378	0.00633	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—malaria	0.000375	0.00629	CbGpPWpGaD
Nabumetone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	0.000372	0.00623	CbGpPWpGaD
Nabumetone—Gastrointestinal pain—Clindamycin—malaria	0.00037	0.00183	CcSEcCtD
Nabumetone—Abdominal pain—Dapsone—malaria	0.00037	0.00183	CcSEcCtD
Nabumetone—Body temperature increased—Dapsone—malaria	0.00037	0.00183	CcSEcCtD
Nabumetone—Feeling abnormal—Quinine—malaria	0.000366	0.00181	CcSEcCtD
Nabumetone—Feeling abnormal—Quinidine—malaria	0.000366	0.00181	CcSEcCtD
Nabumetone—PTGS2—Selenium Micronutrient Network—SCARB1—malaria	0.000365	0.00611	CbGpPWpGaD
Nabumetone—Gastrointestinal pain—Quinidine—malaria	0.000363	0.00179	CcSEcCtD
Nabumetone—Gastrointestinal pain—Quinine—malaria	0.000363	0.00179	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—TNF—malaria	0.000362	0.00606	CbGpPWpGaD
Nabumetone—Insomnia—Pentoxifylline—malaria	0.000362	0.00179	CcSEcCtD
Nabumetone—Nausea—Sulfadiazine—malaria	0.000361	0.00178	CcSEcCtD
Nabumetone—Urticaria—Clindamycin—malaria	0.00036	0.00177	CcSEcCtD
Nabumetone—MPO—Vitamin B12 Metabolism—IL6—malaria	0.000359	0.00601	CbGpPWpGaD
Nabumetone—Body temperature increased—Clindamycin—malaria	0.000358	0.00177	CcSEcCtD
Nabumetone—Abdominal pain—Clindamycin—malaria	0.000358	0.00177	CcSEcCtD
Nabumetone—Dyspnoea—Quinidine barbiturate—malaria	0.000357	0.00176	CcSEcCtD
Nabumetone—Dyspnoea—Pentoxifylline—malaria	0.000357	0.00176	CcSEcCtD
Nabumetone—Somnolence—Quinidine barbiturate—malaria	0.000356	0.00176	CcSEcCtD
Nabumetone—Somnolence—Pentoxifylline—malaria	0.000356	0.00176	CcSEcCtD
Nabumetone—CYP1A2—Arachidonic acid metabolism—HPGDS—malaria	0.000353	0.00592	CbGpPWpGaD
Nabumetone—Urticaria—Quinidine—malaria	0.000353	0.00174	CcSEcCtD
Nabumetone—Urticaria—Quinine—malaria	0.000353	0.00174	CcSEcCtD
Nabumetone—Dyspepsia—Pentoxifylline—malaria	0.000352	0.00174	CcSEcCtD
Nabumetone—Body temperature increased—Quinidine—malaria	0.000351	0.00173	CcSEcCtD
Nabumetone—Abdominal pain—Quinidine—malaria	0.000351	0.00173	CcSEcCtD
Nabumetone—Abdominal pain—Quinine—malaria	0.000351	0.00173	CcSEcCtD
Nabumetone—Body temperature increased—Quinine—malaria	0.000351	0.00173	CcSEcCtD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—malaria	0.000351	0.00588	CbGpPWpGaD
Nabumetone—Decreased appetite—Quinidine barbiturate—malaria	0.000348	0.00172	CcSEcCtD
Nabumetone—Decreased appetite—Pentoxifylline—malaria	0.000348	0.00172	CcSEcCtD
Nabumetone—Constipation—Quinidine barbiturate—malaria	0.000343	0.00169	CcSEcCtD
Nabumetone—Constipation—Pentoxifylline—malaria	0.000342	0.00169	CcSEcCtD
Nabumetone—Hypersensitivity—Clindamycin—malaria	0.000334	0.00165	CcSEcCtD
Nabumetone—Feeling abnormal—Quinidine barbiturate—malaria	0.00033	0.00163	CcSEcCtD
Nabumetone—Feeling abnormal—Pentoxifylline—malaria	0.00033	0.00163	CcSEcCtD
Nabumetone—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000328	0.00162	CcSEcCtD
Nabumetone—Hypersensitivity—Quinine—malaria	0.000327	0.00161	CcSEcCtD
Nabumetone—Hypersensitivity—Quinidine—malaria	0.000327	0.00161	CcSEcCtD
Nabumetone—Gastrointestinal pain—Pentoxifylline—malaria	0.000327	0.00161	CcSEcCtD
Nabumetone—Asthenia—Clindamycin—malaria	0.000325	0.0016	CcSEcCtD
Nabumetone—PTGS1—Overview of nanoparticle effects—IL6—malaria	0.000324	0.00542	CbGpPWpGaD
Nabumetone—Pruritus—Clindamycin—malaria	0.00032	0.00158	CcSEcCtD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000319	0.00535	CbGpPWpGaD
Nabumetone—Asthenia—Quinine—malaria	0.000319	0.00157	CcSEcCtD
Nabumetone—Asthenia—Quinidine—malaria	0.000319	0.00157	CcSEcCtD
Nabumetone—Urticaria—Quinidine barbiturate—malaria	0.000318	0.00157	CcSEcCtD
Nabumetone—PTGS2—Overview of nanoparticle effects—TNF—malaria	0.000318	0.00533	CbGpPWpGaD
Nabumetone—Urticaria—Pentoxifylline—malaria	0.000318	0.00157	CcSEcCtD
Nabumetone—Abdominal pain—Quinidine barbiturate—malaria	0.000317	0.00156	CcSEcCtD
Nabumetone—Body temperature increased—Quinidine barbiturate—malaria	0.000317	0.00156	CcSEcCtD
Nabumetone—Body temperature increased—Pentoxifylline—malaria	0.000316	0.00156	CcSEcCtD
Nabumetone—Abdominal pain—Pentoxifylline—malaria	0.000316	0.00156	CcSEcCtD
Nabumetone—Pruritus—Quinine—malaria	0.000314	0.00155	CcSEcCtD
Nabumetone—Pruritus—Quinidine—malaria	0.000314	0.00155	CcSEcCtD
Nabumetone—PTGS2—Spinal Cord Injury—FCGR2A—malaria	0.000314	0.00526	CbGpPWpGaD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—malaria	0.000312	0.00522	CbGpPWpGaD
Nabumetone—Diarrhoea—Clindamycin—malaria	0.00031	0.00153	CcSEcCtD
Nabumetone—Diarrhoea—Quinidine—malaria	0.000304	0.0015	CcSEcCtD
Nabumetone—Diarrhoea—Quinine—malaria	0.000304	0.0015	CcSEcCtD
Nabumetone—Dizziness—Clindamycin—malaria	0.000299	0.00148	CcSEcCtD
Nabumetone—Vomiting—Dapsone—malaria	0.000298	0.00147	CcSEcCtD
Nabumetone—Hypersensitivity—Quinidine barbiturate—malaria	0.000295	0.00146	CcSEcCtD
Nabumetone—Hypersensitivity—Pentoxifylline—malaria	0.000295	0.00145	CcSEcCtD
Nabumetone—Dizziness—Quinine—malaria	0.000294	0.00145	CcSEcCtD
Nabumetone—Dizziness—Quinidine—malaria	0.000294	0.00145	CcSEcCtD
Nabumetone—Headache—Dapsone—malaria	0.000293	0.00145	CcSEcCtD
Nabumetone—PTGS1—Biological oxidations—HPGDS—malaria	0.000293	0.0049	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—IL6—malaria	0.000292	0.00489	CbGpPWpGaD
Nabumetone—Vomiting—Clindamycin—malaria	0.000288	0.00142	CcSEcCtD
Nabumetone—Asthenia—Quinidine barbiturate—malaria	0.000288	0.00142	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—TNF—malaria	0.000287	0.00482	CbGpPWpGaD
Nabumetone—Asthenia—Pentoxifylline—malaria	0.000287	0.00142	CcSEcCtD
Nabumetone—Rash—Clindamycin—malaria	0.000285	0.00141	CcSEcCtD
Nabumetone—Dermatitis—Clindamycin—malaria	0.000285	0.00141	CcSEcCtD
Nabumetone—Headache—Clindamycin—malaria	0.000284	0.0014	CcSEcCtD
Nabumetone—Pruritus—Quinidine barbiturate—malaria	0.000284	0.0014	CcSEcCtD
Nabumetone—Pruritus—Pentoxifylline—malaria	0.000283	0.0014	CcSEcCtD
Nabumetone—Vomiting—Quinine—malaria	0.000282	0.00139	CcSEcCtD
Nabumetone—Vomiting—Quinidine—malaria	0.000282	0.00139	CcSEcCtD
Nabumetone—Rash—Quinidine—malaria	0.00028	0.00138	CcSEcCtD
Nabumetone—Rash—Quinine—malaria	0.00028	0.00138	CcSEcCtD
Nabumetone—Dermatitis—Quinidine—malaria	0.00028	0.00138	CcSEcCtD
Nabumetone—Dermatitis—Quinine—malaria	0.00028	0.00138	CcSEcCtD
Nabumetone—Headache—Quinine—malaria	0.000278	0.00137	CcSEcCtD
Nabumetone—Headache—Quinidine—malaria	0.000278	0.00137	CcSEcCtD
Nabumetone—Nausea—Dapsone—malaria	0.000278	0.00137	CcSEcCtD
Nabumetone—Diarrhoea—Quinidine barbiturate—malaria	0.000274	0.00135	CcSEcCtD
Nabumetone—Diarrhoea—Pentoxifylline—malaria	0.000274	0.00135	CcSEcCtD
Nabumetone—Nausea—Clindamycin—malaria	0.000269	0.00133	CcSEcCtD
Nabumetone—Dizziness—Quinidine barbiturate—malaria	0.000265	0.00131	CcSEcCtD
Nabumetone—Dizziness—Pentoxifylline—malaria	0.000265	0.00131	CcSEcCtD
Nabumetone—Nausea—Quinine—malaria	0.000264	0.0013	CcSEcCtD
Nabumetone—Nausea—Quinidine—malaria	0.000264	0.0013	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—CRP—malaria	0.00026	0.00435	CbGpPWpGaD
Nabumetone—PTGS2—Overview of nanoparticle effects—IL6—malaria	0.000257	0.0043	CbGpPWpGaD
Nabumetone—Vomiting—Quinidine barbiturate—malaria	0.000255	0.00126	CcSEcCtD
Nabumetone—Vomiting—Pentoxifylline—malaria	0.000254	0.00126	CcSEcCtD
Nabumetone—Rash—Quinidine barbiturate—malaria	0.000253	0.00125	CcSEcCtD
Nabumetone—Dermatitis—Quinidine barbiturate—malaria	0.000252	0.00125	CcSEcCtD
Nabumetone—Rash—Pentoxifylline—malaria	0.000252	0.00124	CcSEcCtD
Nabumetone—Dermatitis—Pentoxifylline—malaria	0.000252	0.00124	CcSEcCtD
Nabumetone—Headache—Quinidine barbiturate—malaria	0.000251	0.00124	CcSEcCtD
Nabumetone—Headache—Pentoxifylline—malaria	0.000251	0.00124	CcSEcCtD
Nabumetone—PTGS1—Selenium Micronutrient Network—ICAM1—malaria	0.000239	0.004	CbGpPWpGaD
Nabumetone—Nausea—Quinidine barbiturate—malaria	0.000238	0.00117	CcSEcCtD
Nabumetone—Nausea—Pentoxifylline—malaria	0.000238	0.00117	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—IL6—malaria	0.000232	0.00389	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—malaria	0.000227	0.0038	CbGpPWpGaD
Nabumetone—CYP1A2—Phase II conjugation—HPGDS—malaria	0.000225	0.00377	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—CD36—malaria	0.000218	0.00365	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000214	0.00358	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—CRP—malaria	0.000206	0.00346	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000205	0.00344	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	0.000202	0.00338	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—ICAM1—malaria	0.00019	0.00318	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL4—malaria	0.000189	0.00316	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IFNG—malaria	0.000182	0.00305	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000163	0.00273	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL1B—malaria	0.000162	0.00272	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—TNF—malaria	0.000157	0.00263	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TLR4—malaria	0.000156	0.00262	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—ICAM1—malaria	0.00015	0.00251	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—NOS2—malaria	0.000149	0.00249	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	0.000147	0.00246	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—CD4—malaria	0.000145	0.00242	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IFNG—malaria	0.000144	0.00242	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.000137	0.0023	CbGpPWpGaD
Nabumetone—CYP1A2—Biological oxidations—HPGDS—malaria	0.000132	0.0022	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL1B—malaria	0.000129	0.00216	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	0.000122	0.00205	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	0.000122	0.00204	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000118	0.00198	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—TNF—malaria	0.000118	0.00197	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—DHODH—malaria	0.000114	0.00191	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IFNG—malaria	0.000114	0.00191	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—malaria	0.000112	0.00188	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—malaria	0.000103	0.00173	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL1B—malaria	0.000102	0.00171	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL2—malaria	0.000101	0.0017	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SLC4A1—malaria	9.72e-05	0.00163	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL6—malaria	9.49e-05	0.00159	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—TNF—malaria	9.34e-05	0.00156	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	9.22e-05	0.00154	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—DECR1—malaria	9.14e-05	0.00153	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—DHODH—malaria	9.07e-05	0.00152	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—malaria	8.92e-05	0.00149	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	8.88e-05	0.00149	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	8.88e-05	0.00149	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HBB—malaria	8.26e-05	0.00138	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—malaria	8.19e-05	0.00137	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLC4A1—malaria	7.71e-05	0.00129	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL6—malaria	7.54e-05	0.00126	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TNF—malaria	7.39e-05	0.00124	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PKLR—malaria	7.36e-05	0.00123	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—DECR1—malaria	7.25e-05	0.00122	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PKLR—malaria	6.98e-05	0.00117	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—G6PD—malaria	6.56e-05	0.0011	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HBB—malaria	6.56e-05	0.0011	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CD36—malaria	6.48e-05	0.00109	CbGpPWpGaD
Nabumetone—PTGS2—Disease—G6PD—malaria	6.22e-05	0.00104	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL6—malaria	5.96e-05	0.000999	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PKLR—malaria	5.85e-05	0.000979	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—G6PD—malaria	5.21e-05	0.000873	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CD36—malaria	5.14e-05	0.000861	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—DHODH—malaria	5.13e-05	0.00086	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	5.05e-05	0.000846	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malaria	5.02e-05	0.000842	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HPGDS—malaria	5.01e-05	0.000839	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—DHFR—malaria	4.64e-05	0.000778	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	4.64e-05	0.000777	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SCARB1—malaria	4.6e-05	0.00077	CbGpPWpGaD
Nabumetone—PTGS2—Disease—DHFR—malaria	4.4e-05	0.000738	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC4A1—malaria	4.37e-05	0.000731	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—DECR1—malaria	4.1e-05	0.000688	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HPGDS—malaria	3.97e-05	0.000666	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HBB—malaria	3.71e-05	0.000622	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—DHFR—malaria	3.69e-05	0.000618	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SCARB1—malaria	3.65e-05	0.000611	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PKLR—malaria	3.31e-05	0.000554	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—G6PD—malaria	2.95e-05	0.000494	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	2.91e-05	0.000487	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CD36—malaria	2.88e-05	0.000483	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CD36—malaria	2.29e-05	0.000384	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HPGDS—malaria	2.25e-05	0.000377	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS2—malaria	2.25e-05	0.000377	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—DHFR—malaria	2.09e-05	0.00035	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SCARB1—malaria	2.06e-05	0.000346	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD4—malaria	1.66e-05	0.000279	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CD36—malaria	1.3e-05	0.000217	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—malaria	9e-06	0.000151	CbGpPWpGaD
